Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial

John Deanfield, A Michael Lincoff, Steven E Kahn, Scott S Emerson, Ildiko Lingvay, Benjamin M Scirica, Jorge Plutzky, Robert F Kushner, Helen M Colhoun, G Kees Hovingh, Signe Stensen, Peter E Weeke, Ole Kleist Jeppesen, Rafael Bravo, Chau-Chung Wu, Issei Komuro, Ferruccio Santini, Jøran Hjelmesæth, Miguel Urina-Triana, Silvio Buscemi, Donna H Ryan

Open source

DOI: 10.1016/s0140-6736(25)01375-3
Published: 2025-11
Container: The Lancet
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-25-01375-3,
  title = {Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial},
  author = {John Deanfield and A Michael Lincoff and Steven E Kahn and Scott S Emerson and Ildiko Lingvay and Benjamin M Scirica and Jorge Plutzky and Robert F Kushner and Helen M Colhoun and G Kees Hovingh and Signe Stensen and Peter E Weeke and Ole Kleist Jeppesen and Rafael Bravo and Chau-Chung Wu and Issei Komuro and Ferruccio Santini and Jøran Hjelmesæth and Miguel Urina-Triana and Silvio Buscemi and Donna H Ryan},
  year = {2025},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(25)01375-3},
  url = {https://doi.org/10.1016/s0140-6736(25)01375-3}
}

RIS

TY  - JOUR
TI  - Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial
AU  - John Deanfield
AU  - A Michael Lincoff
AU  - Steven E Kahn
AU  - Scott S Emerson
AU  - Ildiko Lingvay
AU  - Benjamin M Scirica
AU  - Jorge Plutzky
AU  - Robert F Kushner
AU  - Helen M Colhoun
AU  - G Kees Hovingh
AU  - Signe Stensen
AU  - Peter E Weeke
AU  - Ole Kleist Jeppesen
AU  - Rafael Bravo
AU  - Chau-Chung Wu
AU  - Issei Komuro
AU  - Ferruccio Santini
AU  - Jøran Hjelmesæth
AU  - Miguel Urina-Triana
AU  - Silvio Buscemi
AU  - Donna H Ryan
PY  - 2025
JO  - The Lancet
DO  - 10.1016/s0140-6736(25)01375-3
UR  - https://doi.org/10.1016/s0140-6736(25)01375-3
ER  -

APA

Deanfield, J., Lincoff, A. M., Kahn, S. E., Emerson, S. S., Lingvay, I., Scirica, B. M., Plutzky, J., Kushner, R. F., Colhoun, H. M., Hovingh, G. K., Stensen, S., Weeke, P. E., Jeppesen, O. K., Bravo, R., Wu, C., Komuro, I., Santini, F., Hjelmesæth, J., Urina-Triana, M., Buscemi, S., & Ryan, D. H. (2025). Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial. The Lancet. https://doi.org/10.1016/s0140-6736(25)01375-3

Source records

crossref · retrieved 2026-09-27T05:55:06.925Z